Every New York stock exchange trading day I’m posting a daily dividend stock or fund review. I’ll share the three chief qualities of just one equity or fund that could be selected for a dividend stock portfolio I’ve named the Safari to Sweet Success.
This week my Safari portfolio seeks a company in the healthcare sector.
That sector includes ten industries all related to testing, diagnosing and treating what ails us. The healthcare industries are: biotechnology; diagnostics & research; drug manufacturers – major; drug manufacturers – specialty & generic; healthcare plans; long-term care facilities; medical care; medical devices, medical distribution; medical supplies.
Today I’m reviewing a drug manufacturer – specialty & generic named Takeda Pharmaceutical Company Limited. Its trading ticker symbol is TKPYY.
Takeda Pharmaceutical Company Limited is a pharmaceutical company in Japan. Their therapeutic products are in oncology, gastroenterology, cardiovascular, and neurology which are marketed in emerging markets and Europe.
The company is also involved in clinical diagnostics, chemical products, and other businesses. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Osaka, Japan.
I use three primary keys to gauge dividend equities or funds like Takeda Pharmaceutical (TKPYY):
(1) Price
(2) Dividends
(3) Returns
TKPYY Price
Takeda Pharmaceutical’s price at Friday’s market close was $28.28 per share. A year ago its price was $23.31. So it gained$4.97 per share in the past year. If TKPYY does as well this year its share price will increase from $28.28 to $33.25, or about 17.6%.
TKPYY Dividends
Takeda Pharmaceutical’s most recent semi-annual dividend was $0.3995 declared September 28th and paid December 11th.
The annual dividend for 2018 is estimated to be $0.80 payable semi-annually in July,and December.
Leave A Comment